Sheharyar Raza Describes the Role of Factor V in Clotting
Sheharyar Raza, Transfusion Medicine Specialist and Data Scientist at University Health Network, shared on LinkedIn:
“Clotting relies on coagulation factors, and people lacking them can bleed severely. Yet some factor deficiencies lack replacement agents. Why?
In a new commentary with Jeremy Jacobs and co-authors, we describe the role of Factor V in clotting, its importance for patients with congenital deficiency, gaps in treatment options, and benefits of Factor V repletion for these (and potentially many other) patients
Article ($$) in Seminars in Thrombosis and Hemostasis.”
Title: From Fresh Frozen Plasma to First-in-human: Bringing Coagulation Factor V Deficiency into Therapeutic Trials
Authors: Jeremy W. Jacobs, Sheharyar Raza, Cristina A. Figueroa Villalba, Brian D. Adkins, Shannon C. Walker, Garrett S. Booth, Deva Sharma, Allison P. Wheeler
Stay informed with Hemostasis Today.
-
Jul 21, 2026, 11:48A Century of VWD: Redefining Its Role Beyond Hemostasis
-
Jul 21, 2026, 08:43Joy Duemke: Optimizing Stem Cell Collection for Gene Therapy Success
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026